[HTML] cell.comFull View

[HTML][HTML] RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells

S Lamba, M Russo, C Sun, L Lazzari, C Cancelliere… - Cell reports, 2014 - cell.com
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …
被引用次数：129 相关文章

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells

S Lamba, M Russo, C Sun, L Lazzari… - Cell …, 2014 - pubmed.ncbi.nlm.nih.gov
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …
[PDF] archive.org

[PDF][PDF] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

C Lieftink, R Bernards, F Di Nicolantonio… - Cell Reports, 2014 - scholar.archive.org
SUMMARY KRAS is the most frequently mutated oncogene in human cancer, yet no
therapies are available to treat KRAS mutant cancers. We used two independent reverse …

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

SE Lamba, M Russo, C Sun, L Lazzari, C Cancelliere… - CELL REPORTS, 2014 - iris.unito.it
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …

RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

S Lamba, M Russo, C Sun, L Lazzari, C Cancelliere… - 2014 - agris.fao.org
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …
[PDF] core.ac.uk

[PDF][PDF] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

C Lieftink, R Bernards, F Di Nicolantonio, A Bardelli - Cell Reports, 2014 - core.ac.uk
SUMMARY KRAS is the most frequently mutated oncogene in human cancer, yet no
therapies are available to treat KRAS mutant cancers. We used two independent reverse …
[HTML] sciencedirect.com

[HTML][HTML] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

S Lamba, M Russo, C Sun, L Lazzari, C Cancelliere… - Cell Reports, 2014 - Elsevier
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …
[PDF] academia.edu

[PDF][PDF] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

C Lieftink, R Bernards, F Di Nicolantonio, A Bardelli - Cell Reports, 2014 - academia.edu
SUMMARY KRAS is the most frequently mutated oncogene in human cancer, yet no
therapies are available to treat KRAS mutant cancers. We used two independent reverse …
[PDF] researchgate.net

[PDF][PDF] RAF Suppression Synergizes with MEK Inhibition in KRAS Mutant Cancer Cells

C Lieftink, R Bernards, F Di Nicolantonio, A Bardelli - Cell Reports, 2014 - researchgate.net
SUMMARY KRAS is the most frequently mutated oncogene in human cancer, yet no
therapies are available to treat KRAS mutant cancers. We used two independent reverse …

RAF suppression synergizes with MEK inhibition in KRAS mutant cancer cells.

S Lamba, M Russo, C Sun, L Lazzari, C Cancelliere… - Cell Reports, 2014 - europepmc.org
KRAS is the most frequently mutated oncogene in human cancer, yet no therapies are
available to treat KRAS mutant cancers. We used two independent reverse genetic …